ZOLEDRONIC ACID
Ossi

OSSI is indicated for the prevention of skeletal-related events (including pathological fractures, spinal cord compression, radiation or surgery to bone, or tumor-induced hypercalcaemia) in adult patients with advanced malignancies involving bone, and for the treatment of adult patients with tumor-induced hypercalcaemia (TIH).

Packaging: Single vial
Shelf Life: 24 months
Origin: India
Dosage Form: Solution for Injection